Anne-Marie Graffin
Chairman at VALNEVA
Net worth: 3 060 $ as of 2024-03-30
Profile
Ms. Anne-Marie Graffin is a Lead Independent Non-Executive Director at Sartorius Stedim Biotech SA, a Deputy Chairman-Supervisory Board at Nanobiotix SA, a Chairman at Valneva SE, a Managing Director & Manager at Smag Consulting SARL and a President & Independent Non-Executive Director at Smag Consulting S.A.S.
She is on the Board of Directors at Sartorius Stedim Biotech SA, Nanobiotix SA, Smag Consulting S.A.S.
and Vétoquinol SA. Ms. Graffin was previously employed as a Member-Supervisory Board by M2care SAS, a Managing Director by Latham BioPharm Group, Inc., a Chief Business Officer by Xcellerex, Inc., a Vice President-Business Management by Sanofi Pasteur MSD SA, a Vice President by Sanofi Pasteur MSD SNC, a Brand Manager by Roc SA, a Marketing Manager by Laboratoires URGO SA, a Manager by Urgo laboratories, a Manager-France Products by International Distillers & Vintners Ltd., a Chief Executive Officer by Big Booster Club, and a Brand Manager by Laboratoires URGO SA. She also served on the board at Themis Bioscience GmbH, Sanofi Pasteur MSD Ltd., Sanofi España SA, Sanofi Pasteur MSD Ltd.
(Ireland) and Sanofi Pasteur MSD SA (Spain).
She received her MBA from ESSEC Business School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
VALNEVA SE
0.00% | 2024-03-03 | 779 ( 0.00% ) | 3 060 $ | 2024-03-30 |
Anne-Marie Graffin active positions
Companies | Position | Start |
---|---|---|
NANOBIOTIX | Director/Board Member | 2013-12-31 |
VALNEVA | Chairman | 2023-12-19 |
SARTORIUS STEDIM BIOTECH | Director/Board Member | 2015-04-06 |
VETOQUINOL SA | Director/Board Member | - |
Smag Consulting SARL | Chief Executive Officer | 2011-08-31 |
Former positions of Anne-Marie Graffin
Companies | Position | End |
---|---|---|
Themis Bioscience GmbH
Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Director/Board Member | 2014-12-31 |
Sanofi Pasteur MSD SNC
Sanofi Pasteur MSD SNC Pharmaceuticals: MajorHealth Technology Sanofi Pasteur MSD SNC is engaged in the wholesale of pharmaceutical products. The company was founded on August 16, 1993 and is headquartered in Lyon, France. | Corporate Officer/Principal | 2010-12-31 |
Sanofi Pasteur MSD SA | Corporate Officer/Principal | 2010-12-31 |
MSD Vaccines Ltd.
MSD Vaccines Ltd. Pharmaceuticals: OtherHealth Technology MSD Vaccines Ltd. manufactures and supplies vaccines. Its main way of achieving this goal is to develop and make available innovative vaccines against a wide spectrum of diseases. It also dedicated to increasing the understanding of the value of vaccines and vaccination by providing relevant and accurate information on their quality, safety and efficacy. The company was founded in 1975 and is headquartered in Maidenhead, the United Kingdom. | Director/Board Member | 2009-12-31 |
░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Anne-Marie Graffin
ESSEC Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
VETOQUINOL SA | Health Technology |
SARTORIUS STEDIM BIOTECH | Health Technology |
NANOBIOTIX | Health Technology |
VALNEVA | Health Technology |
Private companies | 15 |
---|---|
Xcellerex, Inc.
Xcellerex, Inc. Pharmaceuticals: MajorHealth Technology Xcellerex, Inc. manufactures and provides equipment to produce bio-molecules. Its products and services include FlexFactory, a bioprocess manufacturing platform that handles the production of bio-products, such as vaccines, yeast and insulins. The company was founded by Parrish M. Galliher in 2002 and was headquartered in Marlborough, MA. | Health Technology |
International Distillers & Vintners Ltd.
International Distillers & Vintners Ltd. Food DistributorsDistribution Services International Distillers & Vintners Ltd. is a British company that imports and distributes specialty beers and spirits worldwide, including the Americas. The joint venture company's mission is to provide nationwide service to their customers while committing to long term brand building activities. The company prides itself on its broad range of high-quality products, including wines, spirits, and beer from countries around the world. The company is the exclusive importer and distributor of a variety of products. | Distribution Services |
Laboratoires URGO SA
Laboratoires URGO SA Medical SpecialtiesHealth Technology Laboratoires URGO SA provides surgical dressings and adhesive plasters. Its products include tapes, traditional plasters, burn range, podology, and filmogel technology. The company was founded in 1958 and is headquartered in Chenôve, France. | Health Technology |
MSD Vaccines Ltd.
MSD Vaccines Ltd. Pharmaceuticals: OtherHealth Technology MSD Vaccines Ltd. manufactures and supplies vaccines. Its main way of achieving this goal is to develop and make available innovative vaccines against a wide spectrum of diseases. It also dedicated to increasing the understanding of the value of vaccines and vaccination by providing relevant and accurate information on their quality, safety and efficacy. The company was founded in 1975 and is headquartered in Maidenhead, the United Kingdom. | Health Technology |
Sanofi España SA | |
Sanofi Pasteur MSD SA | |
Sanofi Pasteur MSD SNC
Sanofi Pasteur MSD SNC Pharmaceuticals: MajorHealth Technology Sanofi Pasteur MSD SNC is engaged in the wholesale of pharmaceutical products. The company was founded on August 16, 1993 and is headquartered in Lyon, France. | Health Technology |
Themis Bioscience GmbH
Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Health Technology |
Sanofi Pasteur MSD Ltd. (Ireland)
Sanofi Pasteur MSD Ltd. (Ireland) BiotechnologyHealth Technology Part of Merck & Co., Inc., Sanofi Pasteur MSD Ltd. is a private company based in Dublin, Ireland. The Irish company develops and produces vaccines. | Health Technology |
Sanofi Pasteur MSD SA (Spain)
Sanofi Pasteur MSD SA (Spain) Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Sanofi Pasteur MSD SA is a private company based in Madrid, Spain. The Spanish company develops vaccines. | Health Technology |
Smag Consulting SARL | |
Roc SA
Roc SA Real Estate DevelopmentFinance Roc SA provides housing development services. | Finance |
Latham BioPharm Group, Inc.
Latham BioPharm Group, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sia Partners SASU, Latham BioPharm Group, Inc. is a leading life science consulting private company that works with pharmaceutical, biotech, CROs, academia, and medical device/diagnostic companies to solve complex business, regulatory, and product development challenges. The company was founded in 1996 by Peter Latham and is based in Elkridge, MD. LBG's core services include comprehensive functional expertise in vaccines, therapeutics, cell & gene therapy, medical devices, and diagnostics. The company provides technical expertise, quality oversight, strategic analysis, and knowledge management necessary to successfully navigate the complex roadmap of life sciences product development. LBG has helped clients identify, evaluate, fund, manage, and monetize opportunities, generating over $1 billion in non-dilutive funding and over $100 million in licensing fees and investments. Latham BioPharm Group was acquired by Sia Partners SASU on October 14, 2022. | Commercial Services |
M2care SAS
M2care SAS Miscellaneous Commercial ServicesCommercial Services M2care SAS is a French healthcare company founded in 2017. The company is based in Lyon, France. M2care is a team of passionate entrepreneurs who invest in human and financial value to co-found, co-operate, and co-develop innovative projects in the healthcare sector until they reach the patient. | Commercial Services |
Big Booster Club |
- Stock Market
- Insiders
- Anne-Marie Graffin